| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Medical Research Council Group in Molecular Endocrinology, CHUL Research Center and Laval University, Québec City, G1V 4G2, Canada
Address all correspondence and requests for reprints to: Jacques Simard, Laboratory of Hereditary Cancers, T3–57, CHUL Research Center, 2705 Laurier Boulevard, Sainte-Foy, Québec, G1V 4G2, Canada. E-mail: Jacques.Simard{at}crchul.ulaval.ca
The 3ß-hydroxysteroid dehydrogenase/isomerase (3ß-HSD) isoenzymes catalyze an essential step in the formation of all classes of active steroid hormones. In humans there are two 3ß-HSD isoenzymes, the type 1 gene being predominantly expressed in the placenta and peripheral tissues, whereas the type 2 gene is the predominant 3ß-HSD expressed in the adrenal glands and gonads. We have recently showed that interleukin (IL)-4 and IL-13 induce 3ß-HSD type 1 gene expression in human breast cancer cell lines as well as in normal human mammary epithelial cells. The present study was designed to investigate whether such a cytokine-induced 3ß-HSD type 1 expression would also be observed in cell types derived from other peripheral sex steroid target tissues. To gain further knowledge about the molecular mechanism of IL-4 action, we have studied whether the induction of 3ß-HSD type 1 expression in IL-4-responsive cell types would always be associated with the activation of Stat6, a member of the Signal Transducers and Activators of Transcription (STAT) gene family. Stat6 is recognized as the principal transcription factor mediating the effects of IL-4. In normal human prostate epithelial cells (PrEC), no 3ß-HSD activity was detectable under basal culture conditions, while exposure to IL-4 or IL-13 caused a potent induction of this activity. This effect results from a rapid induction of 3ß-HSD type 1 messenger RNA levels as determined by Northern blot and RT-PCR analyses. Furthermore, IL-4 and IL-13 also increased 3ß-HSD type 1 gene expression in human HaCaT immortalized keratinocytes, ME-180 cervix cancer cells, HT-29 colon cancer cells as well as in BT-20 and ZR-75–1 breast cancer cells. However, IL-4 and IL-13 failed to modulate the 3ß-HSD type 1 expression in human LnCAP and PC-3 prostate cancer cells, Caco-2 colon cancer cells as well as in JAR and JEG-3 choriocarcinoma cell lines. The DNA-binding activity of Stat6 was activated after a 30-min exposure to IL-4 in PrEC and in all the cell types where IL-4 induced 3ß-HSD expression, but not in those that failed to respond to IL-4. Our data therefore suggest that IL-4 and IL-13 may play a role in the biosynthesis of active sex steroids from the inactive adrenal steroid dehydroepiandrosterone, not only in breast cells but also in various cell types derived from peripheral target tissues, such as normal human prostate epithelial cells, immortalized keratinocytes, as well as colon and cervix cancer cell lines. Our data also demonstrates that the stimulatory effect of IL-4 was always associated with the activation of Stat6, thus supporting the essential role of Stat6 in this induction of 3ß-HSD type 1 gene expression.
This article has been cited by other articles:
 |
|
 |
|
  H. Le, J. T. Arnold, K. K. McFann, and M. R. Blackman DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E952 - E960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Guerini, D. Sau, E. Scaccianoce, P. Rusmini, P. Ciana, A. Maggi, P. G.V. Martini, B. S. Katzenellenbogen, L. Martini, M. Motta, et al. The Androgen Derivative 5{alpha}-Androstane-3{beta},17{beta}-Diol Inhibits Prostate Cancer Cell Migration Through Activation of the Estrogen Receptor {beta} Subtype Cancer Res., June 15, 2005; 65(12): 5445 - 5453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Thomas, E. L. Boswell, L. A. Scaccia, V. Pletnev, and T. C. Umland Identification of Key Amino Acids Responsible for the Substantially Higher Affinities of Human Type 1 3{beta}-Hydroxysteroid Dehydrogenase/Isomerase (3{beta}-HSD1) for Substrates, Coenzymes, and Inhibitors Relative to Human 3{beta}-HSD2 J. Biol. Chem., June 3, 2005; 280(22): 21321 - 21328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family Endocr. Rev., June 1, 2005; 26(4): 525 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Arnold, H. Le, K. K. McFann, and M. R. Blackman Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E573 - E584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Steckelbroeck, Y. Jin, S. Gopishetty, B. Oyesanmi, and T. M. Penning Human Cytosolic 3{alpha}-Hydroxysteroid Dehydrogenases of the Aldo-keto Reductase Superfamily Display Significant 3{beta}-Hydroxysteroid Dehydrogenase Activity: IMPLICATIONS FOR STEROID HORMONE METABOLISM AND ACTION J. Biol. Chem., March 12, 2004; 279(11): 10784 - 10795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Thomas, W. L. Duax, A. Addlagatta, S. Brandt, R. R. Fuller, and W. Norris Structure/Function Relationships Responsible for Coenzyme Specificity and the Isomerase Activity of Human Type 1 3{beta}-Hydroxysteroid Dehydrogenase/Isomerase J. Biol. Chem., September 12, 2003; 278(37): 35483 - 35490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Thomas, J. I. Mason, S. Brandt, B. R. Spencer Jr., and W. Norris Structure/Function Relationships Responsible for the Kinetic Differences between Human Type 1 and Type 2 3beta -Hydroxysteroid Dehydrogenase and for the Catalysis of the Type 1 Activity J. Biol. Chem., November 1, 2002; 277(45): 42795 - 42801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Chamoux, A. Narcy, J.-G. Lehoux, and N. Gallo-Payet Fibronectin, Laminin, and Collagen IV as Modulators of Cell Behavior during Adrenal Gland Development in the Human Fetus J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1819 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-l. Chang, S. L. Zheng, G. A. Hawkins, S. D. Isaacs, K. E. Wiley, A. Turner, J. D. Carpten, E. R. Bleecker, P. C. Walsh, J. M. Trent, et al. Joint Effect of HSD3B1 and HSD3B2 Genes Is Associated with Hereditary and Sporadic Prostate Cancer Susceptibility Cancer Res., March 1, 2002; 62(6): 1784 - 1789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Alos, A.-M. Moisan, L. Ward, M. Desrochers, L. Legault, G. Leboeuf, G. Van Vliet, and J. Simard A Novel A10E Homozygous Mutation in the HSD3B2 Gene Causing Severe Salt-Wasting 3{beta}-Hydroxysteroid Dehydrogenase Deficiency in 46,XX and 46,XY French-Canadians: Evaluation of Gonadal Function after Puberty J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1968 - 1974. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Gingras, S. Côté, and J. Simard Multiple Signaling Pathways Mediate Interleukin-4-Induced 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Type 1 Gene Expression in Human Breast Cancer Cells Mol. Endocrinol., February 1, 2000; 14(2): 229 - 240. [Abstract] [Full Text]
|
|
|
|
|
|
New Insight into the Molecular Basis of 3{beta}-Hydroxysteroid Dehydrogenase Deficiency: Identification of Eight Mutations in the HSD3B2 Gene in Eleven Patients from Seven New Families and Comparison of the Functional Properties of Twenty-Five Mutant Enzymes J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4410 - 4425. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
